Advanced Search
Newsfeed
Followed Companies
News Alerts
520Followers on Owler
OverviewCompetitorsAcquisitionsFundingNews & Insights

MiMedx Competitors' Key Highlights

Key Highlights

Sign up for free to see more
Sign up for free to see more
Sign up for free to see more
Product Launch
Integra LifeSciences Launches NeuraGen 3D Nerve Guide Matrix
Mar 22, 2022
Conference Presentation
Organogenesis Holdings Inc. to Present at the Oppenheimer Healthcare Conference
Mar 08, 2022
Fraud
Final Deadline Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Lead Plaintiff Deadline in Securities Fraud Class Action Lawsuit Filed Against Organogenesis Holdings Inc. (ORGO)
Feb 06, 2022
Funding
Organogenesis received $200M in Post-IPO Debt Funding
Aug 10, 2021
Podimetrics received $45M in Series C Funding
Mar 24, 2022

MiMedx Competitors or Alternatives

MiMedx's top competitors include Osiris Therapeutics, Organogenesis and Integra LifeSciences.

Sign up for free to unlock more info

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • CEO

    CEO RATING

    EMPLOYEES

  • FUNDING

    REVENUE

  • CEO

    CEO RATING

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

MiMedx's company profile

Timothy R Wright

CEO

83/100
810
$143.2M
$257.5M

  • Timothy R Wright

    CEO

    83/100
    810
  • $143.2M
    $257.5M

  • Timothy R Wright

    CEO

    83/100
  • 810
    $143.2M
  • $257.5M

  • Timothy R Wright

    CEO

  • 83/100
  • 810
  • $143.2M
  • $257.5M
View ProfileView
1
MiMedx's Competitor - Osiris Therapeutics logo

CEO

- -
360
$127.5M
$150M

  • CEO

    - -
    360
  • $127.5M
    $150M

  • CEO

    - -
  • 360
    $127.5M
  • $150M

  • CEO

  • - -
  • 360
  • $127.5M
  • $150M
View ProfileView
2
MiMedx's Competitor - Organogenesis logo

Gary S. Gillheeney Sr.

President & CEO

93/100
950
$427.4M
$463.6M

  • Gary S. Gillheeney Sr.

    President & CEO

    93/100
    950
  • $427.4M
    $463.6M

  • Gary S. Gillheeney Sr.

    President & CEO

    93/100
  • 950
    $427.4M
  • $463.6M

  • Gary S. Gillheeney Sr.

    President & CEO

  • 93/100
  • 950
  • $427.4M
  • $463.6M
View ProfileView
3
MiMedx's Competitor - Integra LifeSciences logo

Jan De Witte

President & CEO

79/100
3,800
$350M
$1.6B

  • Jan De Witte

    President & CEO

    79/100
    3,800
  • $350M
    $1.6B

  • Jan De Witte

    President & CEO

    79/100
  • 3,800
    $350M
  • $1.6B

  • Jan De Witte

    President & CEO

  • 79/100
  • 3,800
  • $350M
  • $1.6B
View ProfileView
4
MiMedx's Competitor - Isto Biologics logo

Don Brown

CEO

90/100
42
- -
$25M

  • Don Brown

    CEO

    90/100
    42
  • - -
    $25M

  • Don Brown

    CEO

    90/100
  • 42
    - -
  • $25M

  • Don Brown

    CEO

  • 90/100
  • 42
  • - -
  • $25M
View ProfileView
5
MiMedx's Competitor - Amniox Medical logo

Amy Tseng

President & CEO

86/100
80
- -
$5M

  • Amy Tseng

    President & CEO

    86/100
    80
  • - -
    $5M

  • Amy Tseng

    President & CEO

    86/100
  • 80
    - -
  • $5M

  • Amy Tseng

    President & CEO

  • 86/100
  • 80
  • - -
  • $5M
View ProfileView
6
MiMedx's Competitor - Callico Enterprises logo

CEO

- -
15
- -
$ < 1M

  • CEO

    - -
    15
  • - -
    $ < 1M

  • CEO

    - -
  • 15
    - -
  • $ < 1M

  • CEO

  • - -
  • 15
  • - -
  • $ < 1M
View ProfileView
7
MiMedx's Competitor - Tri-state Biologics logo

Jonathan D. Tave

President

- -
35
$150K
$9.7M

  • Jonathan D. Tave

    President

    - -
    35
  • $150K
    $9.7M

  • Jonathan D. Tave

    President

    - -
  • 35
    $150K
  • $9.7M

  • Jonathan D. Tave

    President

  • - -
  • 35
  • $150K
  • $9.7M
View ProfileView
8
MiMedx's Competitor - Podimetrics logo

Jonathan Bloom

Co-Founder & CEO

91/100
35
$85.8M
$5M

  • Jonathan Bloom

    Co-Founder & CEO

    91/100
    35
  • $85.8M
    $5M

  • Jonathan Bloom

    Co-Founder & CEO

    91/100
  • 35
    $85.8M
  • $5M

  • Jonathan Bloom

    Co-Founder & CEO

  • 91/100
  • 35
  • $85.8M
  • $5M
View ProfileView
9
MiMedx's Competitor - Solsys Medical logo

Allan R. Staley

Co-Founder & CEO

90/100
63
- -
$25M

  • Allan R. Staley

    Co-Founder & CEO

    90/100
    63
  • - -
    $25M

  • Allan R. Staley

    Co-Founder & CEO

    90/100
  • 63
    - -
  • $25M

  • Allan R. Staley

    Co-Founder & CEO

  • 90/100
  • 63
  • - -
  • $25M
View ProfileView
10
MiMedx's Competitor - Alliqua logo

David Johnson

CEO

67/100
34
$52.6M
$6.7M

  • David Johnson

    CEO

    67/100
    34
  • $52.6M
    $6.7M

  • David Johnson

    CEO

    67/100
  • 34
    $52.6M
  • $6.7M

  • David Johnson

    CEO

  • 67/100
  • 34
  • $52.6M
  • $6.7M
View ProfileView
11
MiMedx's Competitor - Cesca logo

Chris Xu

Chairman & CEO

77/100
53
$62.6M
$13.1M

  • Chris Xu

    Chairman & CEO

    77/100
    53
  • $62.6M
    $13.1M

  • Chris Xu

    Chairman & CEO

    77/100
  • 53
    $62.6M
  • $13.1M

  • Chris Xu

    Chairman & CEO

  • 77/100
  • 53
  • $62.6M
  • $13.1M
View ProfileView
12
MiMedx's Competitor - Parexel logo

Jamie Macdonald

CEO

91/100
18,000
- -
$2.5B

  • Jamie Macdonald

    CEO

    91/100
    18,000
  • - -
    $2.5B

  • Jamie Macdonald

    CEO

    91/100
  • 18,000
    - -
  • $2.5B

  • Jamie Macdonald

    CEO

  • 91/100
  • 18,000
  • - -
  • $2.5B
View ProfileView
The top 10 competitors in MiMedx's competitive set are Osiris Therapeutics, Organogenesis, Integra LifeSciences, Isto Biologics, Amniox Medical, Callico Enterprises, Tri-state Biologics, Podimetrics, Solsys Medical, Alliqua. Together they have raised over 1.1B between their estimated 23.9K employees. MiMedx has 810 employees and is ranked 4th among it's top 10 competitors. The top 10 competitors average 1,762.

Osiris Therapeutics is MiMedx's #1 rival. Osiris Therapeutics is a Private company that was founded in Columbia, Maryland in 1992. Like MiMedx, Osiris Therapeutics also works within the Biotechnology field. Osiris Therapeutics has 450 fewer employees vs. MiMedx.

Organogenesis is perceived as one of MiMedx's biggest rivals. Organogenesis was founded in 1985, and is headquartered in Canton, Massachusetts. Like MiMedx, Organogenesis also operates in the Biotechnology sector. Organogenesis generates $206.1M more revenue vs. MiMedx.

Integra LifeSciences is a top competitor of MiMedx. Integra LifeSciences is a Public company that was founded in 1989 in Princeton, New Jersey. Integra LifeSciences competes in the Health Care Equipment field. Compared to MiMedx, Integra LifeSciences has 2,990 more employees.

Looking for similar companies to MiMedx?

Trending News for MiMedx and MiMedx's Competitors

Today 1:37 PMStreetInsider
CANTON, Mass., June 30, 2022 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the dev...

Frequently Asked Questions about MiMedx

  1. Who are MiMedx's top competitors?

    MiMedx's top 3 competitors are Osiris Therapeutics, Organogenesis, Integra LifeSciences.

  2. Who is similar to MiMedx?

    Osiris Therapeutics is the most similar to MiMedx. Organogenesis and Integra LifeSciences are also similar to MiMedx.

  1. Are MiMedx and Osiris Therapeutics competitors?

    Yes, Osiris Therapeutics is one of MiMedx’s top competitors.